glp-1 weight loss comparison GLP-1R Agonists for Updated Ranking and Side Effects
Description
ArticlePubMed 14
On April 21, 2026, the day after the application deadline for Medicare Part D plan sponsors to participate in the BALANCE Model, CMS announced that it would not be moving forward with implementation of the BALANCE Model in Medicare in 2027 and instead would be extending the Medicare GLP-1 Bridge to run through the end of 2027
GLP-1 drugs such as Ozempic and Wegovy help manage Type 2 diabetes and support weight loss by suppressing users appetites
The New York Times
I think this will be particularly challenging over the first six months of the program. Will low-income people have better access GLP-1 weight loss medications
After a series of negotiations, the administration announced agreements with the two firms
